Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FXGVS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,673
Award facts
- Contract value 100% obligated
- $1,673.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,673.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56 mL). This delivery order, which carries no set-aside designation, was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025. The contract represents a routine pharmaceutical supply transaction executed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V program with a $500 million ceiling value and a completion date of December 31, 2036. This comprehensive contract, which was awarded on November 13, 2025, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for a full range of pharmaceutical products, biologics, over-the-counter medications, and medical consumables to support military healthcare facilities worldwide. As one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group has demonstrated substantial federal contracting capability across diverse therapeutic categories and specialized pharmaceutical requirements serving the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FXGVS?
SPE2DB26FXGVS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FXGVS worth?
The government has obligated $1,673 on SPE2DB26FXGVS.
Is contract SPE2DB26FXGVS an order under another contract?
Yes. SPE2DB26FXGVS is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB26FXGVS competed?
The extent of competition for SPE2DB26FXGVS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award